Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
Yes it is because the FDA has not approved a generic equivalent even though the active ingredient, epinephrine, has been in use for 100 years and only costs about 3 cents a dose.The FDA drags it's feet all the time
You're the one who loves to compare the US to Europe right?
How come the drugs in Europe are just as safe as ours but don't take anywhere near as long to get to market?
This isn't a question of the time to get to market. this is about a greedy company jacking up the price on sick people.
Do try to keep up.
The CEO went from $2 million a year to $20 million a year. Where do you think that $18 million came from?Congress decided not to regulate drug prices for Medicare long before Obama.
That's what happens when regulation kills competitionThe CEO went from $2 million a year to $20 million a year. Where do you think that $18 million came from?Congress decided not to regulate drug prices for Medicare long before Obama.
Unfortunately the bod watching her company are all ceo's themselves. Their pay has shot up too in recent years.
When they sent jobs overseas, they didn't pass the savings on to consumers they gave themselves raises and bonus'!
Yes it is because the FDA has not approved a generic equivalent even though the active ingredient, epinephrine, has been in use for 100 years and only costs about 3 cents a dose.
So just let people buy a bottle of liquid epi for 20 bucks and let them have syringes to inject themselves
But NOOOOO the fucking government would never allow that
It is because the government regulation is allowing one company to have a monopoly on a product.Yes it is because the FDA has not approved a generic equivalent even though the active ingredient, epinephrine, has been in use for 100 years and only costs about 3 cents a dose.
So just let people buy a bottle of liquid epi for 20 bucks and let them have syringes to inject themselves
But NOOOOO the fucking government would never allow that
No, that wouldn't make sense, either.
But you keep finding a way how this is the government's fault.
Because clearly the government makes you very unhappy.
It is because the government regulation is allowing one company to have a monopoly on a product.
The fact is the epi pen isn't necessary just let people buy epinephrine and the syringes they need to inject it then no one will need to buy an epi pen
It is because the government regulation is allowing one company to have a monopoly on a product.
The fact is the epi pen isn't necessary just let people buy epinephrine and the syringes they need to inject it then no one will need to buy an epi pen
Yes, because we can totally trust someone going through an allergic shock reaction to totally measure out the right amount of medicine and not overdose or underdose himself.
Ahhhh.... Libertarians... The Retards of the political World.
Takes a total moron to not understand it is the government preventing alternative choices for users of the drug. Congrats.Yes it is because the FDA has not approved a generic equivalent even though the active ingredient, epinephrine, has been in use for 100 years and only costs about 3 cents a dose.
So just let people buy a bottle of liquid epi for 20 bucks and let them have syringes to inject themselves
But NOOOOO the fucking government would never allow that
No, that wouldn't make sense, either.
But you keep finding a way how this is the government's fault.
Because clearly the government makes you very unhappy.
That's what happens when regulation kills competitionThe CEO went from $2 million a year to $20 million a year. Where do you think that $18 million came from?Congress decided not to regulate drug prices for Medicare long before Obama.
Unfortunately the bod watching her company are all ceo's themselves. Their pay has shot up too in recent years.
When they sent jobs overseas, they didn't pass the savings on to consumers they gave themselves raises and bonus'!
Takes a total moron to not understand it is the government preventing alternative choices for users of the drug. Congrats.Yes it is because the FDA has not approved a generic equivalent even though the active ingredient, epinephrine, has been in use for 100 years and only costs about 3 cents a dose.
So just let people buy a bottle of liquid epi for 20 bucks and let them have syringes to inject themselves
But NOOOOO the fucking government would never allow that
No, that wouldn't make sense, either.
But you keep finding a way how this is the government's fault.
Because clearly the government makes you very unhappy.
Takes a total moron to not understand it is the government preventing alternative choices for users of the drug. Congrats.
Pentagon spending rose to $57 million over the past year from $9 million in 2008 - an increase driven both by volume and by price hikes that had a bigger bite on prescriptions filled at retail pharmacies, according to the previously unreported data. The Pentagon gets a government discount on EpiPens dispensed at military treatment facilities and by mail order. But nearly half of its spending was at retail pharmacies where it most recently paid an average of $509 for EpiPen and $528 for EpiPen Jr two-packs - three times higher than its discounted rate, the data shows. That may change. Both the Pentagon and Mylan told Reuters that discussions are underway that could extend the military discount to EpiPens filled at retail pharmacies through the use of rebates.
Mylan spokeswoman Nina Devlin declined to comment on the specific Department of Defense spending. She said in an emailed statement that talks were underway to address "any questions or concerns from the agency." She declined to say if any repayment was on the table. A Reuters analysis of the data estimated a difference of about $54 million between what the agency paid for EpiPens at retail pharmacies from 2009 through 2016 and what it would have paid at military clinics.
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington
Mylan Chief Executive Officer Heather Bresch has drawn public scrutiny for raising the U.S. list price on a pack of two injectors nearly six-fold to $600 since 2008. Affordability has become a bigger issue with the increased diagnosis and awareness of food allergies. Families who rely on EpiPens to safeguard their children against possibly fatal allergic reactions often purchase several to carry with them, keep at school and with caregivers.
In response to the criticism, Mylan is providing more families with coupons to pay for EpiPens and plans to market a half-price version. The drugmaker also agreed to pay $465 million to settle questions over whether the Medicaid program for the poor overpaid because EpiPens were classified as a generic treatment, a category that allows manufacturers to give smaller rebates to government agencies. While Medicaid providers don't take issue with the increased use of EpiPens, they have bristled over the price hikes. "The rate of increases in their cost is not justifiable," said Dr. J. Mario Molina, chief executive of Molina Healthcare, which runs Medicaid plans in California and 11 other states.
THE FULL PICTURE
